Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

Cancer cell | May 17, 2011

http://www.ncbi.nlm.nih.gov/pubmed/21575865

Recurrent fusions of ETS genes are considered driving mutations in a diverse array of cancers, including Ewing's sarcoma, acute myeloid leukemia, and prostate cancer. We investigate the mechanisms by which ETS fusions mediate their effects, and find that the product of the predominant ETS gene fusion, TMPRSS2:ERG, interacts in a DNA-independent manner with the enzyme poly (ADP-ribose) polymerase 1 (PARP1) and the catalytic subunit of DNA protein kinase (DNA-PKcs). ETS gene-mediated transcription and cell invasion require PARP1 and DNA-PKcs expression and activity. Importantly, pharmacological inhibition of PARP1 inhibits ETS-positive, but not ETS-negative, prostate cancer xenograft growth. Finally, overexpression of the TMPRSS2:ERG fusion induces DNA damage, which is potentiated by PARP1 inhibition in a manner similar to that of BRCA1/2 deficiency.

Pubmed ID: 21575865 RIS Download

Mesh terms: Animals | Antineoplastic Agents | Catalytic Domain | Cell Line, Tumor | Cell Movement | Chick Embryo | Chromatin Immunoprecipitation | DNA Damage | DNA-Activated Protein Kinase | Enzyme Inhibitors | Gene Expression Regulation, Neoplastic | Gene Fusion | Genes, Reporter | HEK293 Cells | Humans | Male | Mass Spectrometry | Mice | Mice, Inbred BALB C | Mice, Nude | Mice, SCID | Models, Molecular | Neoplasm Invasiveness | Oncogene Proteins, Fusion | Phthalazines | Piperazines | Poly(ADP-ribose) Polymerases | Prostatic Neoplasms | Protein Conformation | RNA Interference | Recombinant Fusion Proteins | Time Factors | Transcriptional Activation | Transfection | Tumor Burden | Xenograft Model Antitumor Assays

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: K99 CA129565
  • Agency: NCI NIH HHS, Id: P50 CA069568
  • Agency: NCI NIH HHS, Id: P50 CA069568-05
  • Agency: NCI NIH HHS, Id: P50CA69568
  • Agency: NCI NIH HHS, Id: R00 CA129565
  • Agency: NCI NIH HHS, Id: R00 CA129565-03
  • Agency: NCI NIH HHS, Id: R01 CA132874
  • Agency: NCI NIH HHS, Id: R01 CA132874-01A1
  • Agency: NCI NIH HHS, Id: R01 CA132874-02
  • Agency: NCI NIH HHS, Id: R01 CA132874-03
  • Agency: NCI NIH HHS, Id: R01 CA132874-04
  • Agency: NCI NIH HHS, Id: R01CA132874
  • Agency: NCI NIH HHS, Id: U01 CA111275
  • Agency: NCI NIH HHS, Id: U01 CA111275-04
  • Agency: NCI NIH HHS, Id: U01 CA111275-05
  • Agency: NCI NIH HHS, Id: U01 CA111275-05S1
  • Agency: NCI NIH HHS, Id: U01 CA111275-06
  • Agency: NCI NIH HHS, Id: U01 CA111275-07
  • Agency: NCI NIH HHS, Id: UO1 CA113913

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.